Devdiscourse
Development News Edition
Give Feedback
write for Us

Dr Reddy's to launch OTC acid reflux treatment drug in US market

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg is an over-the counter (OTC) therapeutic equivalent generic version of Nexium 24 hour capsules.


PTI India
Updated: 20-07-2018 12:03 IST
Dr Reddy's to launch OTC acid reflux treatment drug in US market

DRL shares were trading 1.61 per cent up at Rs 2,063.55 apiece on the BSE. (Image Credit: Facebook)

Drug major Dr Reddy's Laboratories (DRL) today announced the launch of over-the-counter Esomeprazole magnesium delayed release capsules USP, 20 mg, used to treat acid reflux, in the US market.

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg is an over-the counter (OTC) therapeutic equivalent generic version of Nexium 24 hour capsules.

"This launch continues to demonstrate our deep R&D and manufacturing capabilities to bring newer store-brand OTC medications to the market," Dr Reddy's Laboratories Vice President and Head, US OTC and Speciality Rx businesses, Milan Kalawadia said.

Quoting IRI data, the company said the combined market of Nexium 24 hour capsules and private label OTC Esomeprazole Magnesium products had US sales of approximately USD 311 million for the most recent 12 months ending in May 2018.

DRL shares were trading 1.61 per cent up at Rs 2,063.55 apiece on the BSE.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

COUNTRY : IndiaUnited States

POST A COMMENT